Indefinite Delivery Contract SPE2DU25D9421

The key information from the provided federal contract IDV award is as follows:

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The $499,999,999 IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract supports the medical supply needs of military health facilities globally and covers various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The original solicitation, expected to be issued in March 2024, is for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to establish multiple Prime Vendor Contracts for worldwide pharmaceutical support to the Defense Health Agency, DoD customers, the U.S. Coast Guard, and other government agencies. The estimated total value of the procurement is $30.3 billion, and awards will be made on a regional basis with the intention of having at least three different contractors. The contract type is a firm-fixed-price, requirements contract with a 30-month base period and three 30-month option periods.